Lectenz® Bio News – Lectenz Bio

February 29, 2024 0 0

It’s Rare Disease Day 2024! We’re always excited to see how glycobiology research impacts patient treatments and are proud to be...

December 7, 2023 0 0

Glycan analysis poses significant challenges due to the intricate nature of glycan structures and their diverse compositions, making comprehensive...

November 10, 2023 0 0

Lectenz Bio attended and sponsored the Society for Glycobiology 2023 Annual Meeting in Hawaii. VP of R&D Sean Wu presented our poster...

September 20, 2023 0 0

Lectenz Bio has recently signed a distribution agreement with Labscoop, a U.S. life science distributor. This agreement will allow Labscoop to...

September 17, 2023 0 0

Lectenz Bio has recently signed a distribution agreement with Apical Lab Corp., a Taiwanese life science distributor. This agreement will allow...

September 15, 2023 0 0

The National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) awards Lectenz Bio an SBIR Phase II to further...

July 21, 2023 0 0

The National Institute of Health (NIH) Office of Research Infrastructure Programs (ORIP) awards Lectenz Bio an SBIR Fast-Track to develop N-glycan...

March 31, 2023 0 0

Lectenz Bio has recently signed a distribution agreement with ZAGENO, a European life science distributor. This agreement will allow ZAGENO to...

December 1, 2022 0 0

Cedarlane is now distributing Lectenz Bio products for Canadian customers. We are excited to have Cedarlane listing our catalog and look forward...

November 1, 2022 0 0

Lectenz Bio has recently signed a distribution agreement with MBL Beijing Biotech Co., Ltd., a Chinese life science distributor. This agreement...

June 9, 2022 0 0

Lectenz Bio has recently signed a distribution agreement with Scientist.com, a U.S. life science distributor. This agreement will allow...

May 4, 2022 0 0

Lectenz Bio was excited to have CEO Lori Yang and VP of R&D Sean Wu present at the Common Fund GlycoScience Program!